Global Pharmaceuticals & Biotech Big Green Snowflakes

Qualigen Therapeutics

Market Cap: US$2.9m

A clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer.

Curanex Pharmaceuticals

Market Cap: US$200.6m

A developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases.

Galectin Therapeutics

Market Cap: US$294.7m

A clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases.

Galera Therapeutics

Market Cap: US$1.3m

A biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer.

Resverlogix

Market Cap: CA$28.6m

A late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses.

Pure Biologics

Market Cap: zł22.0m

A biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases.

Pharmadrug

Market Cap: CA$1.6m

Operates as a specialty pharmaceutical company.

BetterLife Pharma

Market Cap: US$10.0m

A biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.

Ovation Science

Market Cap: CA$1.8m

Engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States.

Raphael Pharmaceutical

Market Cap: US$4.3m

A pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids.

EuBiologics

Market Cap: ₩529.2b

A biopharmaceutical company, provides vaccines for pidemics in South Korea.

SAMSUNG PHARM

Market Cap: ₩166.0b

Manufactures and sells pharmaceutical products in South Korea.

Chengdu huasun technology group

Market Cap: CN¥2.5b

Chengdu huasun technology group Inc. , LTD.

Nextage Therapeutics

Market Cap: ₪29.2m

A pharmaceutical company, develops cannabinoid-based products.

TaiMed Biologics

Market Cap: NT$21.9b

A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.

DAE HWA Pharmaceutical

Market Cap: ₩249.4b

A pharmaceutical company, produces and supplies pharmaceutical products in South Korea.

Beijing Biostar Pharmaceuticals

Market Cap: HK$1.9b

A synthetic biology-driven biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology products in the People’s Republic of China.

Molecule Holdings

Market Cap: CA$488.9k

Engages in production and co-packing of cannabis-infused beverages in Canada.

Sangui Biotech International

Market Cap: €419.8k

Through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products.

Advanced Proteome Therapeutics

Market Cap: CA$205.6k

Through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States.

Albert Labs International

Market Cap: CA$372.1k

A biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom.

PharmAbcine

Market Cap: ₩88.0b

PharmAbcine Inc., a clinical-stage biotech company, develops human therapeutic monoclonal antibody (mAb) for the treatment of neovascular disorders, tumors, and other medically unmet diseases.

Asia Green Biotechnology

Market Cap: CA$543.7k

Does not have significant operations.

Capha Pharmaceuticals

Market Cap: US$64.0

Does not have significant operations.

One World Products

Market Cap: US$4.4m

Engages in the sale of cannabidiol based products in the United States.

Jyong Biotech

Market Cap: US$3.9b

A science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia.

Northwest Biotherapeutics

Market Cap: US$376.4m

A biotechnology company, focuses on developing personalized immune therapies for cancer.

Nirvana Life Sciences

Market Cap: CA$410.0k

Engages in the research and development of therapeutic products to address addiction.

Bakhu Holdings

Market Cap: US$6.0m

Produces, manufactures, and sells cannabis-related byproducts for medical, food additive, and recreational use.

Biomind Labs

Market Cap: US$1.2m

A biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions.

GlobeStar Therapeutics

Market Cap: US$1.2k

A clinical stage pharmaceutical company, engages in the provision of patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases in the United States.

Mosaic ImmunoEngineering

Market Cap: US$5.7m

A development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.

SinoMab BioScience

Market Cap: HK$3.1b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics in Mainland China and Hong Kong.

Kadimastem

Market Cap: ₪106.8m

A biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases.

BINEX

Market Cap: ₩563.4b

Operates as a pharmaceutical company in South Korea.

Xinjiang Tianshan Animal Husbandry Bio-engineering

Market Cap: CN¥2.5b

Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.